These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8856833)

  • 41. The H1-receptor antagonist chlorpheniramine decreases the ending phase of the mismatch negativity of the human auditory event-related potentials.
    Serra JM; Escera C; Sánchez-Turet M; Sánchez-Sastre J; Grau C
    Neurosci Lett; 1996 Jan; 203(2):77-80. PubMed ID: 8834097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of antihistaminics with norepinephrine uptake: a cocaine-like effect.
    Isaac L; Goth A
    Life Sci; 1965 Oct; 4(19):1899-904. PubMed ID: 4378998
    [No Abstract]   [Full Text] [Related]  

  • 45. Cocaine and antihistaminic compounds: comparison of effects of some cardiovascular actions of norepinephrine, tyramine and bretylium.
    Johnson GL; Kahn JB
    J Pharmacol Exp Ther; 1966 Jun; 152(3):458-68. PubMed ID: 4380726
    [No Abstract]   [Full Text] [Related]  

  • 46. Discriminable effects of antihistamine drugs.
    Overton DA
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):221-6. PubMed ID: 28095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers.
    Silverman K; Griffiths RR
    J Exp Anal Behav; 1992 Jan; 57(1):91-107. PubMed ID: 1548451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for perceptual masking of the discriminative morphine stimulus.
    Gauvin DV; Young AM
    Psychopharmacology (Berl); 1989; 98(2):212-21. PubMed ID: 2502792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discriminative stimulus effects of H(1)-anti-histamines in cocaine-trained pigeons.
    Zacny JP
    Behav Pharmacol; 1989; 1(3):261-265. PubMed ID: 11224038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice.
    Tagashira E; Kachur JF; Carter WH; Dewey WL
    J Pharmacol Exp Ther; 1984 Apr; 229(1):214-7. PubMed ID: 6707938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure.
    Frey JM; Mintzer MZ; Rush CR; Griffiths RR
    Psychopharmacology (Berl); 1998 Jul; 138(1):16-26. PubMed ID: 9694522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative stimulus properties of valproic acid in the pigeon.
    Picker M; Wallace S; Hancock S; Poling A
    Psychopharmacology (Berl); 1985; 87(4):449-53. PubMed ID: 3936104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EFFECT OF SOME DRUGS UPON RAT BRAIN HISTAMINE CONTENT.
    GREEN H; ERICKSON RW
    Int J Neuropharmacol; 1964 Jul; 3():315-20. PubMed ID: 14333283
    [No Abstract]   [Full Text] [Related]  

  • 56. Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect.
    Shannon HE; Herling S
    J Pharmacol Exp Ther; 1983 Oct; 227(1):160-6. PubMed ID: 6137554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-generalization between a cocaine cue and two antihistamines.
    Gauvin DV; Carl KL; Briscoe RJ; Vallett M; Holloway FA
    Eur J Pharmacol; 1995 Dec; 294(1):281-8. PubMed ID: 8788442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histamine H1 receptors on adherent rheumatoid synovial cells in culture: demonstration by radioligand binding and inhibition of histamine-stimulated prostaglandin E production by histamine H1 antagonists.
    Taylor DJ; Woolley DE
    Ann Rheum Dis; 1987 Jun; 46(6):425-30. PubMed ID: 2888437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihistaminic-opioid combination: effect on locomotor activity in mice.
    Sansone M
    Pol J Pharmacol Pharm; 1988; 40(5):515-23. PubMed ID: 3253717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice.
    Sansone M; D'Udine B; Renzi P; Vetulani J
    Psychopharmacology (Berl); 1987; 93(2):155-7. PubMed ID: 2892221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.